COMMUNIQUÉS West-GlobeNewswire

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
25/03/2025
Expands market-leading position with new best-in-class bunion technologies PONTE VEDRA, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical [...]
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
25/03/2025
Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), Immune Thrombocytopenia (ITP), and Systemic Lupus Erythematosus (SLE) [...]
Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025
25/03/2025
TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, [...]
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
25/03/2025
Successfully Completed Private Placements with Aggregate Gross Proceeds of Approximately $125 Million to Support Advancement of Two Registrational Studies for TNX-103 in PH-HFpEF and Fund Operations through 2027 Phase 3 [...]
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
25/03/2025
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
25/03/2025
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery [...]
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
25/03/2025
MENLO PARK, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, [...]
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
25/03/2025
— Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) infections — SILVER SPRING, Md., March 25, 2025 (GLOBE NEWSWIRE) -- [...]
Glass House Brands Reports Record Setting Fourth Quarter 2024 Financial Results
25/03/2025
Full year net revenue was $200.9 million, a 25% increase year-over-year Fourth quarter revenue was $53.0 million, up 31% year-over-year reflecting over 20% growth in all three business segments Fourth quarter adjusted [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
25/03/2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment
25/03/2025
Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
25/03/2025
IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the [...]
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
25/03/2025
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and Novel Mechanism of [...]
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
25/03/2025
DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, [...]
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
25/03/2025
Cutting-Edge Research Results Showcase AI-Powered Drug Discovery VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing [...]
Animal Protection Groups Petition Minnesota Court to Issue Search Warrant to Investigate Jennie-O Over Use of VSD+
25/03/2025
Records reveal the company killed thousands of turkeys using “ventilation shutdown plus,” which causes heatstroke LITCHFIELD, Minn., March 25, 2025 (GLOBE NEWSWIRE) -- This week, the Animal Legal Defense Fund (ALDF) and [...]
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
25/03/2025
WARREN, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug [...]
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
25/03/2025
Company announcement – No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a [...]
Hapbee - The Future of Wellness Tech - Takes Center Stage With Gary Brecka on ‘The Ultimate Human’ Podcast
25/03/2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Imagine optimizing your sleep, focus, and mood—all without ingesting a single substance. That’s the power of Hapbee Technologies Inc. (TSXV: HAPB; OTCQB: [...]

Pages